NSE filing, NSE: EXICOM. Summary written from the filing by ALFA Finder's alert engine.
Exicom Tele-Systems Ltd: key numbers
- Share price
- ₹132.07
- Market cap
- ₹1,838 Cr
- Revenue (annual)
- ₹1,152 Cr
- Net profit (annual)
- ₹-274.1 Cr
- P/E (TTM)
- -7.1×Sector 21.0×
- Promoter holding
- 65.20%+0.00% QoQ
- FII holding
- 0.97%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Exicom Tele-Systems Ltd
All →Exicom Tele-Systems Other Announcement
Exicom Tele-Systems Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended September 30, 2026.
Exicom Tele-Systems Annual General Meeting
Exicom Tele-Systems Limited held its 32nd Annual General Meeting on September 28, 2026. The company successfully transacted all business items outlined in the meeting notice.
Exicom Tele-Systems Legal & Regulatory
Exicom Tele-Systems Ltd received a customs order imposing a duty liability and penalties totaling ₹18.83 Crore concerning goods classification under the Customs Act, 1962.
- Value
- ₹18.83 Cr
Exicom Tele-Systems Legal & Regulatory
Exicom Tele-Systems received a customs order demanding Rs. 14.49 Crore in duty, plus penalties. The company is evaluating the order and plans to appeal.
- Value
- ₹14.49 Cr
Exicom Tele-Systems Price Movement Clarification
Exicom Tele-Systems Limited clarified that the significant increase in its trading volume is market-driven. The company confirmed no undisclosed material events exist.
Exicom Tele-Systems Other Announcement
Exicom Tele-Systems Limited has submitted its Business Responsibility and Sustainability Report for the financial year 2025-26 as mandated by SEBI Listing Regulations.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date